4//SEC Filing
CLAFLIN THOMAS M II 4
Accession 0001181431-04-034903
CIK 0000919745other
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 3:46 PM ET
Size
14.1 KB
Accession
0001181431-04-034903
Insider Transaction Report
Form 4
CLAFLIN THOMAS M II
Director
Transactions
- Other
Common Sock
2004-07-08$5.43/sh+67,938$368,903→ 67,938 total - Other
Common Stock
2004-07-08$5.43/sh−4,778$25,945→ 4,778 total(indirect: Shares held by Seven Partners) - Other
Common Stock
2004-07-08$5.43/sh+7,097$38,537→ 7,097 total(indirect: Shares held by Claflin Profit Sharing Plan) - Other
Common Stock
2004-07-08$5.43/sh−946,411$5,139,012→ 79 total(indirect: Held by Claflin Capital and Black Diamond Fund)
Holdings
- 40,000
Non-qualified stock option
Exercise: $3.45From: 2004-09-17Exp: 2013-09-17→ Common Stock (30,000 underlying) - 10,000
Non-qualified stock option
Exercise: $6.02From: 2004-05-24Exp: 2014-05-24→ Common Stock (10,000 underlying) - 60,000
Non-qualified stock option
Exercise: $0.80From: 2004-04-02Exp: 2013-04-02→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Each of Claflin Capital and Black Diamond Funds distributed, in a non-open market transaction, shares held by the respective partnership to its limited partners, including Mr. Claflin.
- [F2]The price used for the distribution was the closing price on July 8, 2004.
Documents
Issuer
POINT THERAPEUTICS INC
CIK 0000919745
Entity typeother
Related Parties
1- filerCIK 0001187889
Filing Metadata
- Form type
- 4
- Filed
- Jul 11, 8:00 PM ET
- Accepted
- Jul 12, 3:46 PM ET
- Size
- 14.1 KB